REPORT – ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Post author:Marianne Duparc Post published:June 24, 2022 Post category:Newsroom ERYTECH Pharma announced that its Annual General Meeting was held on Friday, June 24, 2022. You Might Also Like ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia June 24, 2018 ERYTECH announces two positive DSMB reviews June 22, 2015 ERYTECH Pharma announces the oral presentation of very demonstrative results regarding its technology to Induce specific immune tolerance by antigen loaded erythrocytes. September 7, 2012
ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia June 24, 2018
ERYTECH Pharma announces the oral presentation of very demonstrative results regarding its technology to Induce specific immune tolerance by antigen loaded erythrocytes. September 7, 2012